Stocks TelegraphStocks Telegraph
Stock Ideas

BIO-B Company Profile and Key Details

NYSE : BIO-B

Bio-Rad Laboratories

$293.37
00
Open: 9:46 AM

Price Chart

Stock Price Today

Bio-Rad Laboratories, Inc. (BIO-B) stock remained unchanged at $293.37 a share on NYSE. The stock opened at $293.37, fluctuating between $293.37 to $293.37 during the session.

Stock Snapshot

293.37
Prev. Close
7.9B
Market Cap
293.37
Day Low
87.03
P/E Ratio
3.37082
EPS (TTM)
7.58
Cash Flow per Share
293.37
Open
27.04M
Number of Shares
293.37
Day High
N/A
Free Float in %
303.6
Book Value
268
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Jul 08, 2026293.37293.37293.37293.37309
Jul 07, 2026297.37297.42297.37297.371
Jul 06, 2026291.60291.60291.60291.600
Jul 02, 2026301.00301.00301.00301.008.02
Jul 01, 2026292.15316.59292.15298.870
Jun 30, 2026310.78310.78310.78310.788
Jun 29, 2026320.46320.46320.46320.464.02
Jun 26, 2026317.44317.44317.44317.443
Jun 25, 2026291.99296.49291.99293.80185
Jun 24, 2026291.99296.49291.99296.49187
Jun 23, 2026297.22297.96289.23290.00818
Jun 18, 2026295.00295.00295.00295.000.02
Jun 16, 2026295.00295.00295.00295.001.3
Jun 08, 2026307.60307.60307.60307.6083
Jun 04, 2026319.95321.48319.95321.4815
Jun 01, 2026305.34305.34305.34305.342
May 29, 2026313.65313.65313.65313.6515
May 28, 2026304.15304.15304.15304.154
May 27, 2026304.15304.15304.15304.1559
May 20, 2026276.60276.60276.60276.600

Contact Details

Hercules, CA 94547

United States

https://www.bio-rad.com510 724 7000

About Company

Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and Latin America. The company's business is organized into two main divisions: Life Science and Clinical Diagnostics. The Life Science division develops and provides a comprehensive array of reagents, laboratory apparatus, and instruments. These are vital for various applications, including scientific research methodologies, biopharmaceutical production processes, and food quality testing. This segment dedicates its efforts to key areas within the life sciences, such as proteomics, genomics, biopharmaceutical development, cellular biology, and ensuring food safety. Its diverse clientele includes academic institutions (universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology researchers, and both food producers and testing laboratories. Conversely, the Clinical Diagnostics division specializes in designing, producing, selling, and supporting diagnostic test systems, informatics solutions, test kits, and specific quality control measures for clinical laboratories. This segment furnishes reagents, instrumentation, and software precisely tailored to address particular requirements within the in vitro diagnostics market. Its products are utilized by reference laboratories, hospital labs, state-operated newborn screening facilities, physicians' private offices, and blood transfusion centers. Furthermore, Bio-Rad offers systems and products designed for separating intricate chemical and biological substances, as well as for identifying, analyzing, and purifying their individual components. The company distributes its offerings through a multi-channel approach, leveraging both its direct sales force and a network of distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was established in 1952 and its corporate headquarters are located in Hercules, California.

Company Information

Employees7700
Beta1.08
Sales or Revenue$2.67B
5Y Sales Change%0.191%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Devices

Company Overview

Bio-Rad Laboratories, Inc. (NYSE:BIO-B) closed at $293.37 USD, losing -$3.12 (-1.05%) from the previous close of $296.49. The stock is currently mid-range between its 52-week high and low $244.54 and $321.12. With a market capitalization of about $7.90 billion, Bio-Rad Laboratories, Inc. is classified as a mid-cap and shows market-like volatility (beta ~1.08). Key stats such as the average daily volume over the past year has been around 112.00 shares, trading with heavier-than-usual volume. Headquartered in Hercules, CA, Bio-Rad Laboratories, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Norman D. Schwartz, the company employs approximately 7,700 people and listed since September 21, 1999. Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics.

Technical Performance

BIO-B has shown mixed momentum, gaining 0.3% over the past week and -1.91% over the past quarter, though year-to-date performance is down -1.91%. Average 10-day trading volume of 47.15 shares is below the 3-month average of 187.35, indicating normal recent market interest.

Valuation Metrics

Bio-Rad Laboratories, Inc. trades at a P/E ratio of 46.39, slightly above the S&P 500 average, with a price-to-sales ratio of 2.96 and a price-to-book ratio of 1.12 suggesting the stock is closer to book value. The P/FCF stands at 21.45, also above market averages.

Dividend & Fair Value

Bio-Rad Laboratories, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $166.83. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

Bio-Rad Laboratories, Inc. earnings surprise history is a mixed track record. The quarter that ended April 30, 2026, missed forecasts by -1072.64%. The prior quarter beat by -6.69%. Over the last six quarters, Apple has recorded several small beats. These include 566.86% in July 31, 2025.

Shareholding & Insider Activity

Bio-Rad Laboratories, Inc. has 5.07 million shares outstanding. This equals 29.00 shares. The short ratio is 1.71 days. Institutional investors hold 3.08% of the float. Insiders own 98.05%. GOETZ JOHN holds 61.17 thousand shares, Magni Giovanni has 20.74 thousand shares and HERTIA JOHN has 18.73 thousand shares.

Price Forecast & Outlook

Our AI price prediction model suggests that Bio-Rad Laboratories, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Bio-Rad Laboratories, Inc. (NYSE:BIO-B) shares are flat -1.91% year-to-date Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Bio-Rad Laboratories, Inc. trading at a premium to the broader market with a P/E of 46.39.

Frequently Asked Questions

What is the current Bio-Rad Laboratories, Inc. (BIO-B) stock price?
Bio-Rad Laboratories, Inc. (NYSE: BIO-B) stock price is $293.37 in the last trading session. During the trading session, BIO-B stock reached the peak price of $293.37 while $293.37 was the lowest point it dropped to. The percentage change in BIO-B stock occurred in the recent session was 0% while the dollar amount for the price change in BIO-B stock was $0.00.
BIO-B's industry and sector of operation?
The NYSE listed BIO-B is part of Medical - Devices industry that operates in the broader Healthcare sector. Bio-Rad Laboratories, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of BIO-B?
No Data
How BIO-B did perform over past 52-week?
BIO-B's closing price is 19.97% higher than its 52-week low of $244.54 where as its distance from 52-week high of $321.12 is -8.64%.
How many employees does BIO-B have?
Number of BIO-B employees currently stands at 7,700.
Link for BIO-B official website?
Official Website of BIO-B is: https://www.bio-rad.com
How do I contact BIO-B?
BIO-B could be contacted at phone 510 724 7000 and can also be accessed through its website. BIO-B operates from 1000 Alfred Nobel Drive, Hercules, CA 94547, United States.
How many shares of BIO-B are traded daily?
BIO-B stock volume for the day was 268 shares. The average number of BIO-B shares traded daily for last 3 months was 114.
What is the market cap of BIO-B currently?
The market value of BIO-B currently stands at $7.90B with its latest stock price at $293.37 and 27.04M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph